Leonardo Malimpensa

Via Atinense 18, IS
Pozzilli, 86077, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Resting-State EEG Microstates as Dynamic Biomarkers of Network Dysfunction and Cognitive Impairment in Patients With Multiple Sclerosis.

Resting-State EEG Microstates as Dynamic Biomarkers of Network Dysfunction and Cognitive Impairment in Patients With Multiple Sclerosis.

Journal: Neurology

Published: March 19, 2026

Moral decision making and moral judgment in multiple sclerosis.

Moral decision making and moral judgment in multiple sclerosis.

Journal: Neuropsychology

Published: September 18, 2025

TMS-EEG signatures of motor network dysfunction in multiple sclerosis.

TMS-EEG signatures of motor network dysfunction in multiple sclerosis.

Journal: Brain communications

Published: July 06, 2025

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.

Journal: Neurology and therapy

Published: May 25, 2025

Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study.

Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study.

Journal: Therapeutic advances in neurological disorders

Published: March 13, 2025

Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis.

Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: August 22, 2024

Exploring miRNAs' Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis.

Exploring miRNAs' Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis.

Journal: International journal of molecular sciences

Published: May 08, 2024

Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off.

Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off.

Journal: Scientific reports

Published: February 25, 2024

Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer's disease progression: a systematic review.

Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer's disease progression: a systematic review.

Journal: Alzheimer's research & therapy

Published: January 25, 2024

Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules.

Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules.

Journal: Multiple sclerosis and related disorders

Published: January 22, 2024

The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis.

The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis.

Journal: Biology

Published: December 12, 2023

Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).

Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).

Journal: European journal of neurology

Published: September 19, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026